2013

European Medicines Agency Accepts Marketing Authorization Application for Dalbavancin
December 23, 2013


Audax Health Names David Ko President and Chief Operating Officer
December 19, 2013


Chimerix Appoints Linda M. Richardson as Chief Commercial Officer
December 18, 2013


US FDA Grants Orphan Drug Designation to Versartis’ Treatment for Growth Hormone Deficiency
December 18, 2013


Kit Check launches Anesthesia Check to automate Operating Room Syringe Labeling and Medication Tracking
December 9, 2013


Kit Check Announces a Pharmacy Kit Accelerator Program with No Cost for Software and Hardware
December 3, 2013


Durata Therapeutics Announces FDA's Acceptance for Priority Review of NDA for Dalvance™ (dalbavancin hydrochloride)
November 26, 2013


Oxford Immunotec Global PLC Announces Pricing of Initial Public Offering
November 22, 2013


Relypsa, Inc. Announces Pricing of Initial Public Offering
November 14, 2013


ReShape Medical® Successfully Meets Endpoints in Weight Loss Device Pivotal Trial
November 7, 2013


Advanced Cell Diagnostics Announces Genoptix® as their First CLIA Certified RNAscope® Service Provider
November 5, 2013


Karyopharm Therapeutics Announces Pricing of Initial Public Offering
November 5, 2013


Direct Flow Medical® Transcatheter Aortic Valve System Continues To Demonstrate Excellent Outcomes at Six Months in Discover CE Mark Trial
October 29, 2013


Advanced Cell Diagnostics and Kindstar Global Announce Partnership to Launch Cancer Diagnostic Tests in China
October 23, 2013


Relypsa Reports Positive Topline Results for its 52-Week Phase 2b Trial of Patiromer
October 17, 2013


CardioKinetix Announces First Heart Failure Patients Treated in China with Novel Minimally Invasive Structural Heart Device
October 14, 2013


Spiracur and Century Medical Announce Multiple SNaP System Sales in Japan After Ministry of Health, Labor and Welfare Grants Reimbursement
October 14, 2013


Versartis Closes $20 Million Series D Venture Financing
October 8, 2013


Chimerix Announces Proposed Public Offering of Common Stock
October 8, 2013


TigerText Goes Freemium; Launches Next Generation of its Secure Enterprise Messaging App for BYOD
October 3, 2013


Durata Therapeutics Presents New Comprehensive Review of the Efficacy and Safety Data of Dalbavancin and New In Vitro Findings at IDWeek 2013™
October 2, 2013


Treato Expands US Presence and Leadership Team with New Senior Executive Hires
October 2, 2013


Durata Therapeutics Announces NDA Submission for Dalbavancin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
September 26, 2013


Chimerix Announces Publication of Positive Phase 2 Results of Brincidofovir (CMX001) in the New England Journal of Medicine
September 26, 2013


Transcept And Shin Nippon Biomedical Laboratories Announce Global Licensing Agreement For Advanced Acute Migraine Treatment
September 25, 2013


TigerText Provides Integrated, Secure Communication Network for Hartford HealthCare and UConn’s School of Medicine Residency Program
September 24, 2013


Chronic Wounds and High Risk Surgical Incisions Successfully Treated with Spiracur’s Ultraportable Negative Pressure Wound Therapy System
September 24, 2013


NxStage Introduces Web-Based Dosing Calculator
September 23, 2013


Oxford Immunotec Wins Place Again on The Sunday Times Hiscox Tech Track 100
September 18, 2013


Chimerix Presents Brincidofovir (CMX001) Adenovirus Phase 2 Results
September 11, 2013


Catalyst Pharmaceutical Partners, Inc. Closes Previously Announced $15.1 Million Registered Direct Offering
September 10, 2013


MEI Pharma Acquires PWT143, A Highly Selective PI3-Kinase Delta Inhibitor
September 10, 2013


Relypsa Reports Positive Top-Line Results for the First Part of Its Two-Part Pivotal Phase 3 Trial of Patiromer
September 10, 2013


New Treato Pharma Release Brings Real-time "Patient Voice" Intelligence into the Executive Suite
September 10, 2013


Durata Therapeutics Presents New Pivotal Phase 3 Clinical Results and New In Vitro Data on Dalbavancin at ICAAC
September 10, 2013


First Patient Enrolls in U.S. Salus Trial Evaluating Direct Flow Medical® Transcatheter Aortic Heart Valve System
September 10, 2013


Afferent Pharmaceuticals Reports Positive Phase 2 Clinical Data for the Company’s Lead P2X3 Antagonist, AF-219
September 9, 2013


New Leaf Venture Partners Affirms Its Support of Roumell Asset Management’s Letter to Transcept Pharmaceuticals' Board
September 9, 2013


Chimerix Initiates Phase 3 SUPPRESS Trial of Brincidofovir (CMX001) for Prevention of CMV in HCT Recipients
September 9, 2013


Whisper App User Engagement Jumps 140% with TigerText’s In-App Messaging
September 6, 2013


IlluminOss Medical Appoints Dwayne Montgomery as Senior VP of Sales and Marketing
August 27, 2013


TigerText Sees Record Growth in First Half of 2013; Number of Paid Users Quadruples as Enterprise and Healthcare Adoption Jumps
August 22, 2013


TigerText Expands Partnership with AMiON; Provides Healthcare Professionals with Easier and More Secure Way to Coordinate Care
August 15, 2013


Korea Approves NeuroStar TMS for Treating Depression
August 14, 2013


Chimerix Announces Top Line Data From CMX001 Phase 2 Adenovirus Study and Late-Breaker Presentation at ICAAC
August 14, 2013


Kit Check Raises $10.4 million from New Leaf, Sands, Easton and LionBird
July 16, 2013


AstraZeneca Completes Acquisition of Pearl Therapeutics
June 28, 2013


Sprint Launches Secure Messaging Solutions to Enable HIPAA Compliance
June 24, 2013


Pearl Therapeutics to be Acquired by AstraZeneca for up to $1.15 Billion
June 10, 2013


Concert Pharmaceuticals Initiates Phase 1 Clinical Trial of CTP-354, a Potential Treatment for Spasticity and Pain
June 10, 2013


Chimerix and BARDA Continue Collaboration on Development of CMX001 as a Medical Countermeasure Against Smallpox
June 3, 2013


Direct Flow Medical Transcatheter Aortic Valve System Demonstrates Excellent 30 Day Outcomes Following Full Enrollment of DISCOVER CE Mark Trial
May 22, 2013


CardioKinetix Announces Positive Clinical Data Showing Consistent Compelling Positive Results for Patients Treated with Minimally Invasive Structural Heart Device for Heart Failure
May 22, 2013


Direct Flow Medical® Receives IDE Approval for U.S. Salus Trial of Transcatheter Aortic Heart Valve System
May 16, 2013


TigerText and AirWatch Partner to Offer Comprehensive Mobile Security Solution for Healthcare
May 16, 2013


Relypsa Announces Appointment of John Orwin as Chief Executive Officer
May 15, 2013


Relypsa Completes Patient Enrollment in Pivotal Phase 3 Program for the Treatment of Hyperkalemia
May 13, 2013


Pearl Therapeutics Initiates PT003 Phase 3 Program for the Treatment of Individuals with Moderate-to-Severe COPD
May 13, 2013


Concert Pharmaceuticals Announces Strategic Collaboration with Celgene Corporation to Develop Deuterium-Modified Compounds
May 6, 2013


Spine Wave Announces U.S. FDA’s 510K Clearance of the StaXx® IB System, an Intervertebral Body Fusion Device
April 29, 2013


Treato Raises $14.5m from OrbiMed, New Leaf and Reed Elsevier
April 23, 2013


Durata Therapeutics Closes Public Offering of Common Stock
April 17, 2013


Chimerix Announces Pricing of Initial Public Offering
April 11, 2013


Oxford Immunotec wins 2013 Red Herring Top 100 Award
April 11, 2013


MEI Pharma’s Mitochondrial Inhibitor Drug Candidate ME-344 Delays Tumor Growth in Recurrent Ovarian Cancer Model
April 10, 2013


iRhythm Secures $16 Million in Funding Led by Norwest Venture Partners to Fuel Continued Market and Technology Expansion
April 10, 2013


NxStage Completes Move to Direct Sales In UK
April 8, 2013


MEI Pharma Announces $15.2 Million Registered Offering of Common Stock
April 5, 2013


VaxInnate Awarded U.S. Government Grant to Develop Dengue Vaccine
April 4, 2013


Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer
March 21, 2013


NeuroStar TMS Therapy, a Non-Drug Depression Treatment, Demonstrates Statistically Significant Benefits on Patient-Reported Pain Outcomes
March 19, 2013


Douglas Harrington, MD Addresses Select Group of Physicans Regarding Latest Advances in Cardiovascular Risk Assessment
March 19, 2013


Pearl Therapeutics Receives Award for Innovative Co-Suspension Technology
March 14, 2013


Direct Flow Medical® Transcatheter Aortic Valve System Demonstrates Excellent Six-Month Outcomes In Discover Trial
March 12, 2013


Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
March 5, 2013


AccessClosure, Inc. Launches MynxGrip™ Vascular Closure Device
February 27, 2013


ReShape Medical Completes Enrollment of Pivotal Clinical Trial for Weight Loss Device
February 25, 2013


Durata Therapeutics Announces Preliminary, Topline Phase 3 Clinical Trial Results for Dalbavancin in the Treatment of ABSSSI
February 25, 2013


NxStage Announces CE Mark Approval, First Clinical Use of its Single Needle for Dialysis Patients
February 25, 2013


Relypsa Enrolls Initial Patient in Pivotal Phase 3 Program for the Treatment of Hyperkalemia
February 20, 2013


Oxford Immunotec and Lophius Biosciences sign licensing and collaboration agreements
January 29, 2013


Pearl Therapeutics Strengthens Its Organization by Hiring Dr. Michael Riebe, an Industry Veteran in Respiratory Product Development
January 17, 2013


athenahealth to Acquire Mobile Health Leader Epocrates
January 7, 2013


Relypsa Announces Agreement with FDA on Special Protocol Assessment for Patiromer Phase 3 Trial for the Treatment of Hyperkalemia
January 2, 2013